This does not include data for individuals who did not receive testing by a provider or in a health care setting (e.g., individuals who tested positive with an at-home or over-the-counter COVID-19 ...

But a test of a neutralizing antibody’s capabilities showed the neutralizing antibodies prompted by Scharffenberger’s ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

Cases of COVID-19 have waned in the weeks since the launch of the latest booster shot and the beginning of the academic ...

Just like adults under 60, elderly adults who get RSV tend to have mild symptoms, such as runny nose, sore throat, cough, ...

Symptoms of viruses like COVID and flu overlap with each other, but there are ways you can narrow it down to get the ...

But which ones should you get? This year marks the second season for the new respiratory syncytial virus vaccine (RSV) for grown-ups. While not everyone needs it, the evidence so far suggests that ...

RSV neutralizing antibodies for Clover’s non-adjuvanted SCB-1019 matched GSK’s AS01 E-adjuvanted AREXVY in older adults, while demonstrating significantly better tolerability compared to AREXVY — — ...

-- Head-to-head clinical results indicate a potential best-in-class combined efficacy & safety profile of non-adjuvanted bivalent RSV vaccine candidate (SCB-1019)-- -- RSV neutralizing antibodies for ...